Current role
Drug Manufacturers - General · Healthcare
Board Member
2026-11-01–present
Paul J. Diaz
Board Member
Merck & Co., Inc. (MRK)Equibles does not estimate personal net worth.
Get an email with a short summary when Merck & Co., Inc. publishes a filing, an earnings call transcript or a press release.
Get MRK alertsAbout Paul J. Diaz
Paul J. Diaz is recorded as Board Member at Merck & Co., Inc. (MRK) since November 1, 2026. Merck & Co., Inc. reported in an 8-K filed October 13, 2026 that Paul J. Diaz was appointed member of the Board of Directors, effective November 1, 2026. Merck & Co., Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Merck & Co., Inc. includes Robert M. Davis (CEO, Chairman and Board Member), Jennifer Zachary (General Counsel), Dalton E. Smart III (Chief Accounting Officer) and 7 others.
“announcing the election of Paul J. Diaz to the Company's Board of Directors (the "Board"), effective November 1, 2026.”
Affiliation history
-
Current
2026-11-01–present
Company network
Leadership on record at Merck & Co., Inc.
- Robert M. Davis CEO, Chairman, Board Member
- Jennifer Zachary General Counsel
- Dalton E. Smart III Chief Accounting Officer
- Christine E. Seidman Board Member
- J.H. Noseworthy Board Member
- Kathy J. Warden Board Member
- P.B. Rothman Board Member
- P.J. Craig Board Member
- R.B. Lazarus Board Member
- Stephen L. Mayo Board Member